IGHA1 and neoplasm: (165) identified WAKMAR2 eRNA as a key candidate biomarker in invasive breast cancer, which may influence the tumour microenvironment by regulating the relevant immune-related genes, such as RAC2, IL27RA, IGLV1-51, IGHD, IGHA1 and FABP7.